Search results for C-terminal

Anti-CD11b antibody [EP1345Y] - C-terminal, Abcam, AB52478

What is this antibody validated in? Anti-CD11b antibody [EP1345Y] - C-terminal (ab52478) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Immunoprecipitation (IP), Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF) in Human samples. What is the molecular weight of CD11b? Anti-CD11b [EP1345Y] - C-terminal (ab52478) specifically detects a band for CD11b (UniProt: P11215) at a molecular weight of 128kDa. Trusted by the scientific community Anti-CD11b [EP1345Y] - C-terminal (ab52478) was first used in a scientific publication in 2007 and has been cited over 70 times in peer-reviewed journals. Reviewed by scientists Anti-CD11b [EP1345Y] - C-terminal (ab52478) has over 5 independent reviews from customers. Trial sizes available! Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies. Other related products We have a range of other formats of antibody clone [EP1345Y] also available for your convenience: ab52478, Carrier free - ab187537 , PE - ab213186 , APC - ab221248 , Oligonucleotide - ab284435 Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-CD11b antibody [SP330] - C-terminal, Abcam, AB224805

Anti-CD11b antibody [SP331] - C-terminal, Abcam, AB224800

Anti-CD11c antibody [EP1347Y] - C-terminal, Abcam, AB52632

Anti-CD11c antibody [EP1347Y] - C-terminal (ab52632) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in IHC-P, IP, WB in human samples. Anti-CD11c antibody [EP1347Y] - C-terminal (ab52632) has been cited over 119 times in peer reviewed journals and is trusted by the scientific community. Abcams high quality manufacturing and validation processes ensure Anti-CD11c antibody [EP1347Y] - C-terminal (ab52632) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility. Anti-CD11c antibody [EP1347Y] - C-terminal (ab52632) has 16 independent reviews from customers. Anti-CD11c antibody [EP1347Y] - C-terminal (ab52632) specifically detects CD11c (UniProt ID: P20702; Molecular weight: 126kDa) and is sold in a convenient trial size to enable initial testing (20 uL) and larger sizes for subsequent scaling up experiments (100 uL and 1 mL). Conjugation-ready, carrier free format available for antibody clone EP1347Y - ab216655 . Antibody clone EP1347Y is also available pre-conjugated to a variety of labels for your convenience - HRP, Alexa Fluor® 647, Alexa Fluor® 488, Alexa Fluor® 594, Alexa Fluor® 555, Biotin ( ab195534 , ab275338 , ab275738 , ab277235 , ab279329 , ab32232). CD11c is a marker for dendritic cells, playing a pivotal role in antigen presentation and immune regulation, particularly in autoimmune diseases. CD11c is a potential therapeutic target in anti-tumor immune responses, multiple sclerosis and rheumatoid arthritis. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-CD130 (gp130) antibody - C-terminal, Abcam, AB226346

Anti-CD130 (gp130) antibody - C-terminal, Abcam, AB227058

Anti-OVCA1 antibody [EPR15342] - C-terminal, Abcam, AB185960

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-PADI2 / PAD2 antibody - C-terminal, Abcam, AB183194

Anti-Parathyroid Hormone antibody - C-terminal, Abcam, AB227757

Anti-SCIN antibody [EPR16310] - C-terminal, Abcam, AB199723

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .